We partner with world-class management teams to build best-of-breed businessesview all
Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump
Rapidly growing pan-Latin American specialty pharmaceutical company, focused on oncology and critical care drugs
International orthobiologics company focused on bone growth stimulation and joint pain therapies
Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care
"The EW team is extremely knowledgeable, and their ability to identify great innovations and market opportunities, and help move those innovations forward by sharing expertise and assisting in business plan execution is remarkable. AxoGen is proud to have Essex as a partner in our continued growth."
"I have been on the Board of Directors of three EW-backed companies: as Chairman, as Executive Chairman, and as the only US-based Director. EW played a key role in building these three rapidly growing companies, which were all sold for hundreds of millions of dollars. The EW team are true partners with the management teams they back. I look forward to the fourth deal!"
"I am so pleased with our working relationship and the experience, guidance and support that EW provides to EyePoint Pharmaceuticals. The quality of their input, at both the Board level and the management level, has been superb and we have forged a true partnership."
"We are thrilled to partner with EW as the number one healthcare investment firm in the world, with huge successes like Abiomed, Lifecell, and many others. With their understanding of the medical device space and how companies should operate, EW has added value from ‘Day 1’. We were very impressed with the careful diligence conducted by the EW team, and we look forward to a great future together!"